Sanofi
Antibodies against Clostridium difficile toxins and methods of using the same

Last updated:

Abstract:

Monoclonal antibodies, or antigen-binding fragments thereof, that bind to Clostridium difficile (C. difficile) toxin A or toxin B and methods of using the same to detect or treat C. difficile infections and/or C. difficile-associated disease.

Status:
Grant
Type:

Utility

Filling date:

29 Nov 2018

Issue date:

11 Jan 2022